Musculoskeletal- Joint - Inflammatory Disease Flashcards
Rheumatoid Arthritis
Chronic autoimmune inflammatory disease of insidious onset with systemic manifestations including skin, blood vessels, heart, lungs, and muscle.
- Principally produces a symmetric polyarthritis generally affecting mainly small joints in the hands and feet, as well as larger joints such as the wrists and shoulders.
- The arthritis is a sterile proliferative and inflammatory synovitis progressing to destruction of the cartilage and ankylosis of the joint.
AKA: RA, Rheumatoid disease, Atrophic arthritia
Rheumatoid Arthritis - Epidemiology
- Incidence is 0.36/1000 in women, and 0.14 in men per year
- Prevalence is 0.05-0.15/1000 in western countries
- Approx. 1% of adults in the world’s population (including the US) is affected with RA
- Genetic susceptibility, strongly associated with the HLA-DR4 and to a lesser extent to the HLA-DR1 and HLA-DR14 genotypes
Rheumatoid Arthritis - Etiology
- Origin of the autoimmune inflammatory process is unknown
- Unknown antigen involved in triggering the disease
- There is a common genetic varient at the TRAF1-C5 locus on chromosome 9 that is associated with an increased risk of the anti-CCP positive form of RA (TRAF1 gene encodes an intracellular protein that mediates signal transduction involving the TNF receptor)
- Other gene variants associated with risk for RA:
- PTPN22 (T-cell receptor signaling)
- PADI4 (affecting the citrullination of proteins, targets of the anti-CCP antibodies)
Rheumatoid Arthritis - Pathogenesis
- Synovium becomes edematous with perivascular infiltration of myeloid cells
- Fronds or villous projections develop from the synovium
- Infiltration by inflammatory cells (CD4+ T-cells and B-cells)
- release of cytokines IL-1 and TNF-a
- synovial cells to produce prostaglandins and matrix metalloproteinases
- Articular cartilage destruction
- increased vascularity
- Aggregation of fibrin
- Accumulation of neutrophils
- Osteoclastic activity in underlying bone driven by RANKL from T-cells and synovial fibroblasts
- Pannus formation
Rheumatoid Arthritis - Pathology
- Disordered cytoarchitecture in the synovium
- hyperplasia of the resident stromal cells such as fibroblasts
- heavy infiltration of hematopoetic cells such as T and B lymphocytes
- lymphocyte accumulations strongly resemble lymph nodules
- Rheumatoid nodules occur in the dermis but can form in other organs as well
- Vasculitic changes can occur in severe cases
Rheumatoid Arthritis - Presentation
- Usually subacute (20%) or insidious (70%) onset of arthritic symptoms of pain, swelling and stiffness
- Prominent morning stiffness, often lasting hours
- Affected joints are often warm, sometimes reddened
- Can be accompanied by low grade fever and fatigue
- CRITERIA FOR DIAGNOSIS:
- morning stiffness lasting at least 1 hour
- soft tissue swelling of three or more joints
- swelling of the PIP, MCP, or wrist joints
- symmetric arthritis
- Subcutaneous nodules
- postive test for RA factor
- Radiographic erosions or periarticular osteopenia in hand or wrist joints
- joints involved include:
- most common: MCP, wrist and PIP
- knee, shoulder, ankle, hip, and elbow present later
- MTP C-spine, and TMJ can also be involved
- Hand deformities associated with RA include:
- fusiform swelling
- boutonniere deformity
- swan-neck deformity
- ulnar deviation of fingers
Rheumatoid Arthritis - DIagnostic testing
- ESR and CRP levels
- Rheumatoid factor
- Anti-cyclic citrullinated peptide antibody
- Diagnostic Imaging, findings include (ABCDEs):
- characteristic Alignment abnormalities with no ankylosing
- periarticular osteoporosis seen in associated Bones
- Cartilage shows uniform joint space loss
- Deformities present in hand
- Erosions present but are marginal
- soft tissue swelling
Additional tests can include: - CBC
- Serum electrolytes and creatinine levels and liver function tests to monitor therapy
- stool guaiac test to rule out gastrointestinal bleeding
- urinalysis to rule out renal disease if needed
- synovial fluid analysis to rule out crystal deposition diseases in appropriate
Rheumatoid Arthritis - Treatment
- Acetaminophen
- NSAIDs
- Corticosteroids
- DMARDs
- methotrexate
- antimalarial drugs
- sulfasalazine
- leflunomide
- Etanercept
- Infiximab
- Adalimumab
- Rituximab
Rheumatoid Arthritis - Management with compliations
- Depression can be a major issue in patients with RA
- Physical therapy and occupational therapy when needed
- Surgical intervention and joint replacement
Rheumatoid Arthritis - Prevention
- Evidence exists to support the use of complementary therapies involving the elimination of food allergies, vegetarian diet
- Patient Education
- Physical modalities to reduce pain and maintain function such as manipulation, occupational therapy, and physical therapy
- Psychological support and referral for counseling when appropriate
- Dietary modification
Juvenile Idiopathic (Rheumatoid Arthritis)
idiopathic synovitis of the peripheral joints with associated soft tissue swelling and joint effusion. It is one of the most common rheumatic disorders of childhood.
AKA - JRA, Juvenile Rheumatoid Arthritis
Juvenile Idiopathic (Rheumatoid Arthritis) - History
- prevalence of JRA has been estimated to be 57-113 cases per 100,000 children under the age of 16. (may vary by location)
- Most common form of childhood arthritis
- Three types:
- Systemic (10% of cases)
- Polyarticular (40% of cases)
- Pauciarticular or oligoarthritis (50% of cases)
- Pauciarticular and polyarticular disease occur more frequently in girls, while both sexes are affected with equal frequency in systemic onset disease
- Altered bone mineral metabolism
Juvenile Idiopathic (Rheumatoid Arthritis) - Presentation
- Less then 16 years old
- Persistent arthritis in one or more joints for period of 6 weks
- exclusion of all other types of arthritis
- Four KEY POINTS:
- Arthritis: defined as swelling, effusion and two or more of the following:
- Limited range of motion
- Tenderness
- Pain on motion
- Joint warmth
- consistently present for 6 weeks
- more than 10 other causes must be excluded
- Systemic JRA
- number of joints variable
- 1-2 daily fever spikes exceeding 101
- rash
- systemic manifestations
- Polyarticular JRA
- 5 or more joints are involved
- Pauciarticular JRA
- 4 or less joints are involved
Juvenile Idiopathic (Rheumatoid Arthritis) - Diagnostic Testing
- DIagnosis is based o history and clinical presentation
- No lab test can establish diagnosis
- Elevated WBC count
- ESR and C-reactive peptide
- Elevated ANA in 40-85% of cases with poly- or pauarticular JRA
Juvenile Idiopathic (Rheumatoid Arthritis) - treatment
- Pyramid approach:
- beginning with NSAIDs adequate for a minority of children
- many children require:
- Corticosteroids
- Methotrexate
- Sulfasalazine
- Ethanercept
- Infiximab
- Adalimumab
- Adalimumab
- Rituximab
Juvenile Idiopathic (Rheumatoid Arthritis) - Complications
- Disease can persist into adulthood
- Chronic uvitis
- Anemia
Juvenile Idiopathic (Rheumatoid Arthritis) - health promotion
- Psychosocial problems
* Physical and occupational therapies